Over the last five years, nearly all of the major information
technology companies have launched some sort of healthcare initiative. The
COVID pandemic, with its surging demand for telemedicine and rapid exchange of medical
data, only intensifed that trend.
But some tech giants have learned the hard way that healthcare is
very different from other business sectors.
The COVID-19 pandemic has fueled a massive surge in supplement use across the United States, according to data from a new Harris Poll sponsored by the Samueli Foundation. The survey gathered responses from 2,053 US women and men, representing a broad range of ages, ethnicities, and geographical locations. Over three quarters of the respondents (76%) […]
The COVID-19 pandemic has fueled a massive surge in supplement use across the United States, according to data from a new Harris Poll sponsored by the Samueli Foundation. The survey gathered responses from 2,053 US women and men, representing a broad range of ages, ethnicities, and geographical locations. Over three quarters of the respondents (76%) […]
Metabolic
disorders, especially overweight and obesity, diabetes, and dyslipidemia are
some of the most common illnesses all over the world, carrying a high burden of
cardiovascular morbidity and mortality.
In this free webinar, renowned integrative physician Fred Pescatore, MD, will share the science on a soy-derived fibrinolytic enzyme called Bacillopeptidase F, which is shown to improve circulation and normalize biomarkers associated with metabolic disorders.
These
biomarkers include: Hemoglobin A1c, fibrinogen, hS-CRP, total Cholesterol,
HDL-cholesterol, LDL- cholesterol, triglycerides and more.
Isolated from natto, a traditional Japanese
fermented soy food, Bacillopeptidase F Proprietary Blend (BFFB) is a
fibrinolytic protease which can reduce plasminogen activator inhibitor (PAI-1).
When elevated, PAI-1 can impede normal blood circulation.
BFPB, available
as a dietary supplement called Plasmanex1® from Daiwa
Health Development,
maintains
healthy circulation by keeping plasmin and thrombin in balance. It improves circulation, but does not thin the
blood or interfere with blood-thinning medications.
Readily available cardiometabolic biomarkers for
assess and follow-up of varied patient groups
The uses of BFPB in the clinical setting to
optimize patient care
The potential impact of this unique soy-derived
compound in clinical care
Fred Pescatore, MD, MPH, is a Manhattan-based conventionally trained
internist who specializes in nutritional medicine. He is a globally renowned
health, nutrition, and weight loss expert, as well as the author of 9 books
including the New York Times bestsellers, The Hamptons Diet, and The A-List Diet. He is the former president of the International and American
Association of Clinical Nutritionists.
Following a residency at New York Medical
College, Dr. Pescatore’s extraordinary journey in complementary
medicine began in the early 1990s with Dr. Robert Atkins at the Atkins Center
for Complementary Medicine. He then opened his globally recognized medical
center, Medicine 369, in New York City. His rapid expanding practice is
credited as one of the most effective and successful integrative medical centers
in the world, helping tens of thousands of people over in his thirty years of
clinical experience. Dr. Pescatore has studied in America, Southeast Asia,
India, Japan, Africa, and Europe, and is sought after as one of the frontline
educators and visionaries improving health care and human life.
